DFCM
VRTX icon

Dark Forest Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Dark Forest Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-706
Closed -$320K – 1167
2025
Q4 		$320K Sell
706
-1,304
-65% -$562K 0.01% 873
2025
Q3 		$787K Buy
+2,010
New +$840K 0.03% 815
2025
Q1 		– Sell
-1,657
Closed -$667K – 1456
2024
Q4 		$667K Buy
1,657
+585
+55% +$271K 0.1% 312
2024
Q3 		$499K Buy
+1,072
New +$515K 0.06% 387
2022
Q2 		– Sell
-19
Closed -$5K – 1405
2022
Q1 		$5K Buy
19
+17
+850% +$4.04K ﹤0.01% 1112
2021
Q4 		$0 Sell
2
-131
-98% -$25.5K ﹤0.01% 1802
2021
Q3 		$24K Buy
+133
New +$26K 0.01% 766

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dark Forest Capital Management's VRTX Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 706 shares — an estimated $320K sold.

Dark Forest Capital Management first reported a position in VRTX in Q3 2021 and held it in 7 quarters. The position peaked at $787K in Q3 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 706 Vertex Pharmaceuticals shares in Q1 2026, an estimated $320K.
  • Dark Forest Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2021 and held it in 7 quarters.
  • Dark Forest Capital Management's Vertex Pharmaceuticals position peaked at $787K in Q3 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.